Last €6.15 EUR
Change Today +0.235 / 3.97%
Volume 0.0
N8R On Other Exchanges
Symbol
Exchange
London
As of 3:41 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by IMPERIAL INNOVATIONS GROUP P (N8R) in the last 6 months

Announced 01/21/15
Semetric Limited
Merger/Acquisition

Apple Europe Ltd acquired Semetric Limited from Imperial Innovations Group plc (AIM:IVO) and Pentech Ventures recently. For the year ended 2013, Semetric posted loss of £1.4 million and net assets of £1.3 million. Imperial Innovations sold 27.3% stake in Semetric. Post acquisition, Semetric Limited will change its registered office.


N8R's price was unchanged after the transaction was announced on 01/21/15.
Investor / Buyer
Apple Europe Limited
Creditor / Lender
Imperial Innovations Group plc
Pentech Ventures
 
Announced 01/14/15
18.00M for Veryan Medical, Ltd.
Private Placement

Veryan Medical, Ltd. announced that it has received £18 million in its series B round of equity funding led by existing investor Imperial Innovations Group plc on January 14, 2015. The transaction included participation from Seven Mile Capital Partners, INVESCO Asset Management Limited, and existing investor Seroba Kernel Life Sciences Limited. Imperial Innovations Group plc invested £8.40 million in the transaction. Post the closing of the transaction, Imperial Innovations ...
Read More


N8R's price was unchanged after the transaction was announced on 01/14/15.
Investor / Buyer
Imperial Innovations Group plc
INVESCO Asset Management Limited
Seroba Kernel Life Sciences Limited
Seven Mile Capital Partners
 
Announced 01/8/15
Molecular Vision Limited
Merger/Acquisition

Abingdon Health Ltd acquired remaining 45% stake in Molecular Vision Limited from Imperial Innovations Group plc (AIM:IVO) and others on January 8, 2015.


N8R's price was unchanged after the transaction was announced on 01/8/15.
Investor / Buyer
Abingdon Health Ltd
Creditor / Lender
Imperial Innovations Group plc
 
Announced 11/25/14
50.00M for Cell Medica Limited
Private Placement

Cell Medica Limited announced that it has received £50 million in series B round of funding on November 25, 2014. The transaction was led by existing investor, Imperial Innovations Group plc for £15 million and included the participation from existing investor Invesco Perpetual, Woodford Investment Management. Pursuant to the transaction, Imperial Innovations Group will hold 27.9% stake in the company. Rob Wood, Partner and Caroline Drummond, Senior Associate at Osborne ...
Read More


N8R's price was unchanged after the transaction was announced on 11/25/14.
Investor / Buyer
Imperial Innovations Group plc
Invesco Perpetual
Woodford Investment Management LLP
 
Announced 10/8/14
2.00M for Kesios Therapeutics Limited
Private Placement

Kesios Therapeutics Limited announced that it has received £1.85 million in its seed round of equity funding from new investor Imperial Innovations Group plc on October 8, 2014. As a part of the round, the investor acquired a total of 48.4% stake in the company.


N8R's price was unchanged after the transaction was announced on 10/8/14.
Investor / Buyer
Imperial Innovations Group plc
 
Announced 09/23/14
4.00M for Inivata Limited
Private Placement

Inivata Limited announced that it has received £4 million in its first round of funding led by new investor Imperial Innovations Group plc on September 23, 2014. The transaction included participation from new investors Cambridge Innovation Capital PLC which invested £1.5 million and Johnson & Johnson Development Corporation.


N8R's price was unchanged after the transaction was announced on 09/23/14.
Investor / Buyer
Cambridge Innovation Capital PLC
Imperial Innovations Group plc
Johnson & Johnson Development Corporation
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
N8R:GR €6.15 EUR +0.235

N8R Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Health Discovery Corp $0.02 USD 0.00
MDxHealth €5.08 EUR +0.119
Miraculins Inc C$0.18 CAD +0.005
Myriad Genetics Inc $34.79 USD +0.49
Vermillion Inc $1.77 USD -0.0199
View Industry Companies
 

Industry Analysis

N8R

Industry Average

Valuation N8R Industry Range
Price/Earnings 15.3x
Price/Sales 119.2x
Price/Book 1.4x
Price/Cash Flow 20.4x
TEV/Sales 153.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPERIAL INNOVATIONS GROUP P, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.